Selected for MedTech Actuator Accelerator - Cohort 9
ExerWatch has been selected to join the prestigious MedTech Actuator Accelerator program, receiving support and mentorship to bring our technology to market.
Stay up to date with ExerWatch's latest achievements, partnerships, and milestones on our journey to transform exercise monitoring.
ExerWatch has been selected to join the prestigious MedTech Actuator Accelerator program, receiving support and mentorship to bring our technology to market.
Dr. Mahtab Mirmomeni has been recognised as a finalist in the Women of Color in STEM Awards 2024, celebrating her contributions to AI and digital health.
We have commenced a pilot study with Elite Akademy, testing our technology with athletes to refine exercise detection and form analysis capabilities.
ExerWatch has been selected to join the prestigious MedTech Actuator Accelerator program, receiving support and mentorship to bring our technology to market.
Dr. Mahtab Mirmomeni has been recognised as a finalist in the Women of Color in STEM Awards 2024, celebrating her contributions to AI and digital health.
ExerWatch was showcased at the Digital Health Festival 2024 in Melbourne, demonstrating our AI-powered exercise monitoring technology to healthcare leaders.
We have commenced a pilot study with Elite Akademy, testing our technology with athletes to refine exercise detection and form analysis capabilities.
ExerWatch successfully completed the Australian Sports Network Pre-accelerator Program, validating our approach in the sports technology sector.
Dr. Mirmomeni received the International Women's Day Scholarship from Stone & Chalk, recognising her leadership in founding ExerWatch.
Key milestones in ExerWatch's development.
Commercial launch of ExerWatch platform for practitioners and patients.
Selected for MedTech Actuator and Australian Sports Network programs.
Launched pilot study with Elite Akademy to validate technology.
ExerWatch founded with a mission to transform exercise compliance monitoring.
Follow our journey and be the first to know about new developments.